Rentokil Initial plc: Q3 2022 Trading Update & Terminix Acquisition Summary
Business Context and Reporting Period
This Form 6-K filing, dated November 1, 2022, reports the Third Quarter (Q3) 2022 trading update for Rentokil Initial plc. The report covers the period ending September 30, 2022, and details the completion of the acquisition of Terminix on October 12, 2022. The document provides technical guidance for the combined group for the full year 2022, including the "Stub Period" (October 12 to December 31, 2022).
Key Financial Metrics
- Q3 2022 Revenue: Total Revenue was £901.3m (18.9% growth at Actual Exchange Rates (AER), 10.3% at Constant Exchange Rates (CER)). Ongoing Revenue excluding disinfection services was £897.0m (11.7% growth at CER).
- Organic Growth: Group Organic Revenue increased by 6.2% in Q3, supported by price progression. Pest Control Organic Revenue grew 5.0%, while Hygiene & Wellbeing Organic Revenue (excluding disinfection) grew 7.3%.
- Terminix Performance: Terminix delivered its strongest quarterly organic growth since 2014, comparable to Rentokil Initial's group performance.
- Debt and Financing: Net Debt is expected to be in the range of £2.3bn-£2.4bn at year-end. The company issued €850m, €600m, and £400m bonds in June 2022 to fund the cash portion of the Terminix deal and refinance existing debt. Approximately 85% of bond and loan financing is now on fixed interest rates.
- Interest Costs: Full year adjusted interest charges are expected to be £50m-£55m. Cash interest for the full year is expected to be £30m-£35m.
- Exceptional Items: Total cash costs for exceptional items (including deal costs and integration) for the full year are expected to be £100m-£115m.
Material Changes vs. Prior Period
- Disinfection Revenue Decline: Sales from disinfection services decreased by £8.6m compared to the same period last year, falling to £3.6m, in line with post-pandemic expectations.
- Acquisition Activity: The company acquired 12 Pest Control businesses in Q3 with annualized revenues of c.£26.7m. For the nine months to September 30, 2022, 43 businesses were acquired with annualized revenues of c.£95.1m.
- Terminix Integration: The acquisition of Terminix was completed on October 12, 2022. This creates a combined global leader in pest control and hygiene. The transaction involved issuing c.645.71m new shares and a cash element of $1.34bn.
- Accounting Adjustments: A preliminary incremental provision of $265m (£192m at CER) was recognized for termite damage claims under IFRS standards, compared to Terminix's previous US GAAP policy. This is expected to result in a c.£10m non-cash increase to Adjusted Operating Profit in the Stub Period.
Guidance, Outlook, and Risks
- Synergies: The company expects to achieve c.$20m-$25m of annualized synergies by year-end 2022. The actual Adjusted Operating Profit contribution from these synergies in the Stub Period is estimated at $4.1m (£3.0m at CER). Long-term target remains at least $150m annual pre-tax net cost synergies by the third full year post-completion.
- Foreign Exchange: The estimated positive impact of foreign exchange on the P&L for the full year is now c.£20m (excluding Terminix). For the Terminix Stub Period, the positive impact is estimated at £5m-£10m.
- Hyperinflation: Operations in Lebanon, Argentina, and Turkey are subject to hyperinflationary accounting, with full year impacts expected to be £27m-£35m.
- Risks: Key risks include integration challenges with Terminix, failure to achieve synergies, inflationary pressures on costs, supply chain issues, cybersecurity threats, and potential impairment charges. The filing includes standard forward-looking statement disclaimers.
Investor Verification Checklist
- Verify the final purchase price allocation and goodwill booking for the Terminix transaction in the March 2023 Preliminary Results.
- Monitor the realization of the c.$20m-$25m annualized synergies targeted for year-end 2022.
- Track the impact of the $265m termite provision on future Adjusted Operating Profit and cash flow.
- Confirm the final Net Debt position at year-end, which is sensitive to exchange rates and M&A spend execution.
- Review the audited full-year 2022 results in March 2023 for the final impact of hyperinflation accounting and foreign exchange rates.